tradingkey.logo

Avalon Globocare Corp

ALBT
查看详细走势图
0.635USD
+0.032+5.22%
收盘 02/06, 16:00美东报价延迟15分钟
2.60M总市值
亏损市盈率 TTM

Avalon Globocare Corp

0.635
+0.032+5.22%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+5.22%

5天

-19.15%

1月

-47.04%

6月

-73.07%

今年开始到现在

-47.04%

1年

-82.49%

查看详细走势图

TradingKey Avalon Globocare Corp股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Avalon Globocare Corp当前公司基本面数据相对谨慎,最新ESG披露属于行业中等水平。增长潜力较大。当前估值合理,在医疗设备与耗材行业排名149/205位。机构持股占比非常高,中期看,股价处于下降通道。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Avalon Globocare Corp评分

相关信息

行业排名
149 / 205
全市场排名
503 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Avalon Globocare Corp亮点

亮点风险
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
业绩增长期
公司处于发展阶段,最新年度总收入1.33M美元
估值高估
公司最新PE估值-0.08,处于3年历史高位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值25.38K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.97

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Avalon Globocare Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Avalon Globocare Corp简介

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
公司代码ALBT
公司Avalon Globocare Corp
CEOJin (David)
网址https://www.avalon-globocare.com/
KeyAI